UTI Flexi Cap Fund: Picking Stocks with High Earnings Quality
Divya Grover
Jul 07, 2022
Listen to UTI Flexi Cap Fund: Picking Stocks with High Earnings Quality
00:00
00:00
The Indian equity markets have been reeling under pressure and witnessing high volatility amid global uncertainties. While the equity market will continue to face high volatility in the near future, the recent sharp corrections may be considered as a buying opportunity for long-term investors. However, one should focus on diversification to benefit from opportunities across stocks, sectors, and market capitalisation.
Flexi-cap Funds follow a dynamic investment approach and have the flexibility to invest across market cap segments, as per the conviction of the fund manager. The flexible investment mandate allows fund managers to take advantage of changing market conditions to generate higher alpha for investors.
UTI Flexi Cap Fund is an actively managed Flexi Cap Fund that has stood the test of time and rewarded investors with reasonable risk-adjusted returns.
Graph 1: Growth of Rs 10,000 if invested in UTI Flexi Cap Fund 5 years ago
Having a track record of over three decades, UTI Flexi Cap Fund is one of the oldest schemes in the Indian mutual fund industry. While UTI Flexi Cap Fund is not a great bull market performer and may even underperform during market rallies, it surely stands out during bear phases and depressed market conditions. The fund showed stability during the 2018 mid-cap crash, while it also showed a great breakthrough in its performance in the 2020 market crash. With this, UTI Flexi Cap Fund managed to generate a noticeable lead over the benchmark and the category average. In the recent bull phase, UTI Flexi Cap Fund showcased reasonable performance where it initially managed to outpace many of its category peers as well as the benchmark by a big margin but lost its gains when the market started correcting due to its significant exposure to IT and Pharma space. Over the last 5 years, UTI Flexi Cap Fund has registered a growth of around 13.2% CAGR as against 11% CAGR by its benchmark Nifty 500 – TRI, thus outpacing the benchmark by a noticeable margin.
Past performance is not an indicator of future returns
Data as on July 05, 2022
(Source: ACE MF)
Table: UTI Flexi Cap Fund's performance vis-á-vis category peers
Returns are point to point and in %, calculated using the Direct Plan-Growth option. Those depicted over 1-Yr are compounded annualised.
Data as on July 05, 2022
(Source: ACE MF)
*Please note, this table only represents the best performing funds based solely on past returns and is NOT a recommendation. Mutual Fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not an indicator for future returns. The percentage returns shown are only for indicative purposes.
Prior to 2018, UTI Flexi Cap Fund was an average performer; however, the fund has evolved strongly over the last few years. With a CAGR of around 15.9% over the last 3 years and 13.2% over the last 5 years, UTI Flexi Cap Fund has generated an alpha of around 2-3 percentage points over its benchmark Nifty 500 - TRI. The fund stands among the top performers in the category over longer time periods. Though UTI Flexi Cap Fund has trailed the index and has underperformed many of its category peers in the last one year period, it has the potential to bounce back.
The fund's volatility is nearly in line with the benchmark and the category average. Moreover, its Sharpe Ratio of 0.15 is ahead of the category average and the benchmark, signifying its ability to generate reasonable risk-adjusted returns.
Image source: www.freepik.com - photo created by our-team
Join Now: PersonalFN is now on Telegram. Join FREE Today to get 'Daily Wealth Letter' and Exclusive Updates on Mutual Funds
Investment strategy of UTI Flexi Cap Fund
Classified under Flexi Cap Funds category, UTI Flexi Cap Fund is mandated to invest a minimum of 65% of its investment in equity & equity-related instruments with exposure across market caps. However, there is no minimum limit or restriction specified for any market cap segment. Positioned as a Flexi cap fund investing across the market capitalisation spectrum, UTI Flexi Cap Fund holds a portfolio spread across large-cap, mid-cap, and small-cap stocks but with predominant allocation to large caps.
The fund endeavours to pick high-quality businesses run by seasoned quality managements and those having the ability to show strong growth for a long period of time. It focuses on businesses operating in secular growth industries that can generate economic value through the cycle rather than cyclical industries, which are highly volatile. Accordingly, the fund looks for stocks of quality companies that can perform across market cycles and mitigate drawdown during depressed market conditions, whereas rebound faster based on the strong fundamentals of balance sheets & business models.
UTI Flexi Cap Fund follows a bottom-up stock selection process with well-defined metrics of free cash flows, capital efficiency and ability to compound earnings. It usually invests in a well-diversified portfolio of about 55-60 stocks.
Graph 2: Top portfolio holdings in UTI Flexi Cap Fund
Holding in (%) as of May 31, 2022
(Source: ACE MF)
As of May 31, 2022, UTI Flexi Cap Fund held a well-diversified portfolio of 62 stocks. The fund held its top exposure in names like Bajaj Finance, HDFC Bank, ICICI Bank, Kotak Mahindra Bank, and Infosys, collectively accounting for around 23.4% of its assets. Most of the names in the top-10 holdings have been the prominent candidates in the fund's portfolio for over a year now. Notably, UTI Flexi Cap Fund has kept itself away from some of the index heavyweights like Reliance Industries, HUL, etc., and limits the top allocation to a single stock to well under 10%.
In the last one year, UTI Flexi Cap Fund benefitted from its holdings in Schaeffler India, Mindtree, Avenue Supermarts, Grindwell Norton, AU Small Finance Bank, and Titan Company, among others. On the other hand, it lost value in Samvardhana Motherson International, Indiamart Intermesh, Metropolis Healthcare, Dr Lal Pathlabs, HDFC Bank, etc.
Around one-fourth of the fund's portfolio is allocated to stocks in the Banking and Financial sector. Infotech and Consumption follow with a respective allocation of 17% and 10.8%. Pharma, Engineering, Retail, Consumer Durables, Auto & Auto ancillaries, and Chemicals are among the other core sectoral holdings of the fund.
Suitability
UTI Flexi Cap Fund has shown a turnaround performance and made a mark in terms of returns by limiting the downside in the 2020 market crash and participating in the upside rally too. While the rally in large caps has been conducive for the fund's growth, it has managed downsides well during volatile market conditions. Barring the recent underperformance, its superior outperformance recorded in extreme conditions in the past certainly cannot be ignored. The fund has the potential to bounce back strongly and is expected to carry its stellar performance ahead.
The superior performance recorded by the fund in the past has been driven by its smart sector and stock selection strategy. The fund manager has done well to keep volatility at a reasonable level and has delivered in terms of risk-adjusted returns.
UTI Flexi Cap Fund is suitable for investors looking for a prudently managed and relatively stable Flexi Cap Fund for long-term wealth creation.
Warm Regards,
Divya Grover
Research Analyst
PS: If you are looking for quality mutual fund schemes (including Equity-linked Saving Schemes) to add to your investment portfolio, I suggest you subscribe to PersonalFN's premium research service, FundSelect. PersonalFN's FundSelect service provides insightful and practical guidance on which mutual fund schemes to Buy, Hold, and Sell.
Currently, with the subscription to FundSelect, you could also get Free Bonus access to PersonalFN's Debt Fund recommendation service DebtSelect.
If you are serious about investing in a rewarding mutual fund scheme, subscribe now!
Note: This write up is for information purpose and does not constitute any kind of investment advice or a recommendation to Buy / Hold / Sell a fund. Returns mentioned herein are in no way a guarantee or promise of future returns. As an investor, you need to pick the right fund to meet your financial goals. If you are not sure about your risk appetite, do consult your investment consultant/advisor. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
Join Now: PersonalFN is now on Telegram. Join FREE Today to get ‘Daily Wealth Letter’ and Exclusive Updates on Mutual Funds
DISCLOSURE AS PER SECURITIES AND EXCHANGE BOARD OF INDIA (RESEARCH ANALYSTS) REGULATIONS, 2014
About the Company including business activity
Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.
QIS was promoted by Mr Ajit Dayal with an objective of providing value-based information/views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.
'PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc. and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.
Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of the second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.
Disciplinary history
There are no outstanding litigations against the Company, its subsidiaries and its Directors.
Terms and condition on which its offer research report
For the terms and condition for research report click here.
Details of associates
-
Money Simplified Services Private Limited;
-
PersonalFN Insurance Services India Private Limited;
-
Equitymaster Agora Research Private Limited;
-
Common Sense Living Private Limited;
-
Quantum Advisors Private Limited;
-
Quantum Asset Management Company Private Limited;
-
HelpYourNGO.com India Private Limited;
-
HelpYourNGO Foundation;
-
Natural Streets for Performing Arts Foundation;
-
Primary Real Estate Advisors Private Limited;
-
HYNGO India Private Limited;
-
Suresh Lulla;
-
I V Subramaniam.
Disclosure with regard to ownership and material conflicts of interest
-
‘subject company’ is a scheme on which a buy/sell/hold view or target price is given/changed in this Research Report;
-
2. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company;
-
Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report;
-
Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS (PersonalFN) is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However, any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront / annualized & trail), if any, for any Schemes by QMF to QIS (PersonalFN) is also at arm's length and as per prevailing market practices.
Disclosure with regard to receipt of Compensation
-
Neither QIS nor it's Associates have received any compensation from the subject Company in the past twelve months;
-
Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company;
-
Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company;
-
Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.
-
Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report
General disclosure
-
The Research Analyst has not served as an officer, director or employee of the subject Company.
-
QIS or the Research Analyst has not been engaged in market making activity for the subject Company.
Click here to read PersonalFN's Mutual Fund Rating Methodology
Subject Company means Mutual Fund Schemes
Quantum Information Services Private Limited CIN: U65990MH1989PTC054667 Regd. & Corp. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021
Email:info@personalfn.com Website: www.personalfn.com Tel.: 022 61361200 Fax.: 022 61361222 SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013